
NN-Dimethyl-p-phenylenediamine
CAS No. 99-98-9
NN-Dimethyl-p-phenylenediamine( DMPPDA )
Catalog No. M19730 CAS No. 99-98-9
NN-Dimethyl-p-phenylenediamine (DPD DMPD) is an aromatic amine mainly used as an intermediate to produce dyes.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 45 | Get Quote |
![]() ![]() |
10MG | 68 | Get Quote |
![]() ![]() |
25MG | 115 | Get Quote |
![]() ![]() |
50MG | 173 | Get Quote |
![]() ![]() |
100MG | 258 | Get Quote |
![]() ![]() |
200MG | 388 | Get Quote |
![]() ![]() |
500MG | 642 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameNN-Dimethyl-p-phenylenediamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionNN-Dimethyl-p-phenylenediamine (DPD DMPD) is an aromatic amine mainly used as an intermediate to produce dyes.
-
DescriptionNN-Dimethyl-p-phenylenediamine (DPD DMPD) is an aromatic amine mainly used as an intermediate to produce dyes.
-
In Vitro——
-
In Vivo——
-
SynonymsDMPPDA
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number99-98-9
-
Formula Weight136.19
-
Molecular FormulaC8H12N2
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCN(C)c1ccc(N)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
Fluorogestone acetat...
Fluorogestone acetate showed a high potency with short duration of activity and performed physiologically similar to progesterone. FGA was approximately 20 - 25 times more potent than progesterone.
-
Rozanolixizumab
Rozanolixizumab (RYSTIGGO) is a high-affinity humanized immunoglobulin G4 monoclonal antibody targeting Fc receptors (FcRn) in human newborns for the study of pathogenic IgG in autoimmune and alloimmune diseases.
-
Dehydrojuncusol
Dehydrojuncusol, a new inhibitor of hepatitis C virus RNA replication, it inhibits infection of different HCV genotypes by targeting the NS5A protein and is active against resistant HCV variants frequently found in patients with treatment failure.